Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Pharm Biol ; 57(1): 799-806, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31760838

ABSTRACT

Context: Cinnamomum verum J. Presl. (Lauraceae) has a high number of polyphenols with insulin-like activity, increases glucose utilization in animal muscle, and might be beneficial for diabetic patients.Objective: This study evaluated the effectiveness of an ointment prepared from Cinnamomum verum hydroethanolic extract on wound healing in diabetic mice.Materials and methods: A total of 54 male BALB/c mice were divided into three groups: (1) diabetic non-treated group mice that were treated with soft yellow paraffin, (2 and 3) mice that were treated with 5 and 10% C. verum. Two circular full-thickness excisional wounds were created in each mouse, and the trial lasted for 16 d following induction of the wound. Further evaluation was made on the wound contraction ratio, histopathology parameters and mRNA levels of cyclin D1, insulin-like growth factor 1 (IGF-1), glucose transporter-1 (GLUT-1), total antioxidant capacity, and malondialdehyde of granulation tissue contents. HPLC apparatus was utilized to identify the compounds.Results: The HPLC data for cinnamon hydroethanolic extract identified cinnamaldehyde (11.26%) and 2-hydroxyl cinnamaldehyde (6.7%) as the major components. A significant increase was observed in wound contraction ratio, fibroblast proliferation, collagen deposition, re-epithelialization and keratin biosynthesis in the C. verum-treated groups in comparison to the diabetic non-treated group (p < 0.05). The expression level of cyclin D1, IGF1, GLUT 1 and antioxidant capacity increased in the C. verum-treated groups in comparison to the diabetic non-treated group (p < 0.05).Conclusions: Topical administration of C. verum accelerated wound healing and can possibly be employed in treating the wounds of diabetic patients.


Subject(s)
Cinnamomum/chemistry , Keratins/drug effects , Plant Extracts/pharmacology , Re-Epithelialization/drug effects , Wound Healing/drug effects , Administration, Topical , Animals , Antioxidants/adverse effects , Diabetes Mellitus, Experimental/chemically induced , Insulin-Like Growth Factor I/metabolism , Keratins/biosynthesis , Male , Mice , Mice, Inbred BALB C , Ointments , Polyphenols , Skin/drug effects , Streptozocin/pharmacology
2.
Int J Surg ; 12(12): 1409-15, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25448663

ABSTRACT

The repair of peripheral nerve injuries is still one of the most challenging tasks and concerns in neurosurgery, plastic and orthopedic surgery. Effect of acetyl-L-carnitine (ALC) loaded chitosan conduit as an in situ delivery system of ALC in bridging the defects was studied using a rat sciatic nerve regeneration model. A 10-mm sciatic nerve defect was bridged using a chitosan conduit (CHIT/ALC) filled with 10 µL ALC (100 ng/mL). In control group (CHIT), the conduit was filled with the same volume of the phosphate buffered solution. The regenerated fibers were studied 4, 8, 12 and 16 weeks after surgery. The functional and electrophysiological studies confirmed faster recovery of the regenerated axons in ALC treated than control group (P < 0.05). The mean ratios of gastrocnemius muscles weight were measured. There was statistically significant difference between the muscle weight ratios of CHIT/ALC and CHIT groups (P<0.05). Morphometric indices of regenerated fibers showed number and diameter of the myelinated fibers in CHIT/ALC were significantly higher than in control group. In immuohistochemistry, the location of reactions to S-100 in CHIT/ALC was clearly more positive than CHIT group. ALC when loaded in a chitosan conduit resulted in improvement of functional recovery and quantitative morphometric indices of sciatic nerve.


Subject(s)
Acetylcarnitine/pharmacology , Chitosan/therapeutic use , Nerve Regeneration/drug effects , Peripheral Nerve Injuries/drug therapy , Recovery of Function/drug effects , Sciatic Nerve/injuries , Sciatic Nerve/physiology , Tissue Scaffolds , Acetylcarnitine/administration & dosage , Animals , Male , Muscle, Skeletal/anatomy & histology , Organ Size , Peripheral Nerve Injuries/physiopathology , Peripheral Nerves , Rats , Rats, Wistar , Recovery of Function/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...